Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence

Drug and Alcohol Dependence

Volumn 160, Issue , 2016, Pages 49-56

  Morgan, Peter T ^a   Angarita, Gustavo A ^a   Canavan, Sofija ^a   Pittman, Brian ^a   Oberleitner, Lindsay ^a   Malison, Robert T ^a   Mohsenin, Vahid ^b   Hodges, Sarah ^a   Easton, Caroline ^a   McKee, Sherry ^a   Bessette, Andrew ^a   Forselius, Erica ^a  

^a Yale University School of Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Modafinil; Sleep; Slow wave sleep; Treatment

Indexed keywords

MODAFINIL; PLACEBO; BENZHYDRYL DERIVATIVE; WAKEFULNESS PROMOTING AGENT;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SEX DIFFERENCE; SLEEP QUALITY; SLEEP TIME; SLOW WAVE SLEEP; TREATMENT OUTCOME; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; COMPLICATION; DRUG EFFECTS; HOSPITAL PATIENT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OUTPATIENT; PSYCHOLOGY; SLEEP; SLEEP WAKE DISORDERS;

ADULT; BENZHYDRYL COMPOUNDS; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; OUTPATIENTS; SLEEP; SLEEP WAKE DISORDERS; TREATMENT OUTCOME; WAKEFULNESS-PROMOTING AGENTS;

EID: 84960082397     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.12.004     Document Type: Article

References (47)

1. Achermann P., Borbely A.A. Dynamics of EEG slow wave activity during physiological sleep and after administration of benzodiazepine hypnotics. Hum. Neurobiol. 1987, 6:203-210.
2. Anderson A.L., Reid M.S., Li S.H., Holmes T., Shemanski L., Slee A., Smith E.V., Kahn R., Chiang N., Vocci F., Ciraulo D., Dackis C., Roache J.D., Salloum I.M., Somoza E., Urschel H.C., Elkashef A.M. Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 2009, 104:133-139.
3. Angarita G.A., Canavan S.V., Forselius E., Bessette A., Morgan P.T. Correlates of polysomnographic sleep changes in cocaine dependence: self-administration and clinical outcomes. Drug Alcohol Depend. 2014, 143:173-180.
4. Angarita G.A., Canavan S.V., Forselius E., Bessette A., Pittman B., Morgan P.T. Abstinence-related changes in sleep during treatment for cocaine dependence. Drug Alcohol Depend. 2014, 134:343-347.
5. Beck A.T., Steer R.A., Ball R., Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J. Pers. Assess. 1996, 67:588-597.
6. Bellesi M., Riedner B.A., Garcia-Molina G.N., Cirelli C., Tononi G. Enhancement of sleep slow waves: underlying mechanisms and practical consequences. Front. Syst. Neurosci. 2014, 8:208.
7. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index-a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
8. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005, 30:205-211.
9. Dackis C.A., Kampman K.M., Lynch K.G., Plebani J.G., Pettinati H.M., Sparkman T., O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J. Subst. Abuse Treat. 2012, 43:303-312.
10. Dackis C.A., Lynch K.G., Yu E., Samaha F.F., Kampman K.M., Cornish J.W., Rowan A., Poole S., White L., O'Brien C.P. Modafinil and cocaine: a double-blind: placebo-controlled drug interaction study. Drug Alcohol Depend. 2003, 70:29-37.
11. Faulhaber J., Steiger A., Lancel M. The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacology 1997, 130:285-291.
12. Finney J.W., Hahn A.C., Moos R.H. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction 1996, 91:1773-1796. discussion 1803-1720.
13. Greenwood G.L., Woods W.J., Guydish J., Bein E. Relapse outcomes in a randomized trial of residential and day drug abuse treatment. J. Subst. Abuse Treat. 2001, 20:15-23.
14. Hart C.L., Haney M., Vosburg S.K., Rubin E., Foltin R.W. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 2008, 33:761-768.
15. Huber R., Ghilardi M.F., Massimini M., Tononi G. Local sleep and learning. Nature 2004, 430:78-81.
16. Iber C., Ancoli-Israel S., Chesson A.L., Quan S.F. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications 2007, American Academy of Sleep Medicine, Westchester, IL.
17. Jasinski D.R. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J. Psychopharm. 2000, 14:53-60.
18. Kadden R., Carroll K., Donovan D., Cooney N., Monti P., Abrams D., Litt M., Hester R. Cognitive-behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence 1992, National Institute on Alcohol Abuse and Alcoholism, Bethesda.
19. Kampman K.M., Volpicelli J.R., McGinnis D.E., Alterman A.I., Weinrieb R.M., D'Angelo L., Epperson L.E. Reliability and validity of the cocaine selective severity assessment. Addict. Behav. 1998, 23:449-461.
20. Kampman K.M., Lynch K.G., Pettinati H.M., Spratt K., Wierzbicki M.R., Dackis C., O'Brien C.P. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug Alcohol Depend. 2015, 155:105-110.
21. Kate N., Grover S., Ghormode D. Dependence on supratherapeutic doses of modafinil: a case report. Prim. Care Companion CNS Disord. 2012, 14.
22. Kaye S., Darke S. Determining a diagnostic cut-off on the severity of dependence scale (SDS) for cocaine dependence. Addiction 2002, 97:727-731.
23. Kraemer H.C., Wilson G.T., Fairburn C.G., Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Arch. Gen. Psychiatry 2002, 59:877-883.
24. Loland C.J., Mereu M., Okunola O.M., Cao J., Prisinzano T.E., Mazier S., Kopajtic T., Shi L., Katz J.L., Tanda G., Newman A.H. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biol. Psychiatry 2012, 72:405-413.
25. Makris A.P., Rush C.R., Frederich R.C., Taylor A.C., Kelly H. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Exp. Clin. Psychopharmacol. 2007, 15:123-133.
26. Mamelak M., Escriu J.M., Stokan O. The effects of gamma-hydroxybutyrate on sleep. Biol. Psychiatry 1977, 12:273-288.
27. Matuskey D., Pittman B., Forselius E., Malison R.T., Morgan P.T. A multistudy analysis of the effects of early cocaine abstinence on sleep. Drug Alcohol Depend. 2011, 115:62-66.
28. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat 1992, 9:199-213.
29. McLellan A.T., McKay J.R., Forman R., Cacciola J., Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction 2005, 100:447-458.
30. Miller W.R., Del Boca F.K. Measurement of drinking behavior using the Form 90 family of instruments. J. Stud. Alcohol Suppl. 1994, 12:112-118.
31. Morgan P.T., Malison R.T. Pilot study of lorazepam and tiagabine effects on sleep, motor learning, and impulsivity in cocaine abstinence. Am. J. Drug Alcohol Abuse 2008, 34:692-702.
32. Morgan P.T., Paliwal P., Malison R.T., Sinha R. Sex differences in sleep and sleep-dependent learning in abstinent cocaine users. Pharmacol. Biochem. Behav. 2009, 93:54-58.
33. Morgan P.T., Pace-Schott E., Pittman B., Stickgold R., Malison R.T. Normalizing effects of modafinil on sleep in chronic cocaine users. Am. J. Psychiatry 2010, 167:331-340.
34. Morgan P.T., Pace-Schott E.F., Sahul Z.H., Coric V., Stickgold R., Malison R.T. Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: evidence for occult insomnia. Drug Alcohol Depend. 2006, 82:238-249.
35. Morgan P.T., Pace-Schott E.F., Sahul Z.H., Coric V., Stickgold R., Malison R.T. Sleep architecture, cocaine and visual learning. Addiction 2008, 103:1344-1352.
36. Pace-Schott E.F., Stickgold R., Muzur A., Wigren P.E., Ward A.S., Hart C.L., Clarke D., Morgan A., Hobson J.A. Sleep quality deteriorates over a binge-abstinence cycle in chronic smoked cocaine users. Psychopharmacology 2005, 179:873-883.
37. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J. Consult. Clin. Psychol. 2000, 68:250-257.
38. Roth T., Benca R.M., Erman M. An introduction to the clinical correlates of disrupted slow-wave sleep. J. Clin. Psychiatry 2010, 71:e09.
39. Roth T., Schwartz J.R., Hirshkowitz M., Erman M.K., Dayno J.M., Arora S. Evaluation of the safety of modafinil for treatment of excessive sleepiness. J. Clin. Sleep Med. 2007, 3:595-602.
40. Schmitz J.M., Rathnayaka N., Green C.E., Moeller F.G., Dougherty A.E., Grabowski J. Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation. Front. Psychiatry 2012, 3(77).
41. Shipley W.C. A self-administering scale for measuring intellectual impairment and deterioration. J. Psychol. 1940, 9:371-377.
42. Simpson D.D., Joe G.W., Fletcher B.W., Hubbard R.L., Anglin M.D. A national evaluation of treatment outcomes for cocaine dependence. Arch. Gen. Psychiatry 1999, 56:507-514.
43. Stoops W.W., Lile J.A., Fillmore M.T., Glaser P.E., Rush C.R. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology 2005, 182:186-193.
44. Substance Abuse and, Mental Health Services Administration Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings 2014, NSDUH Series H-48. HHS Publication No. (SMA) 14-4863, Rockville, MD.
45. Trksak G.H., Bracken B.K., Jensen J.E., Plante D.T., Penetar D.M., Tartarini W.L., Maywalt M.A., Dorsey C.M., Renshaw P.F., Lukas S.E. Effects of sleep deprivation on brain bioenergetics, sleep, and cognitive performance in cocaine-dependent individuals. ScientificWorldJournal 2013, 2013:947879.
46. Van Dongen H.P., Maislin G., Mullington J.M., Dinges D.F. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003, 26:117-126.
47. Vienne J., Lecciso G., Constantinescu I., Schwartz S., Franken P., Heinzer R., Tafti M. Differential effects of sodium oxybate and baclofen on EEG, sleep, neurobehavioral performance, and memory. Sleep 2012, 35:1071-1083.